Security National Bank of Sioux City Iowa IA Has $1.50 Million Position in DENTSPLY SIRONA Inc. (XRAY)

Security National Bank of Sioux City Iowa IA boosted its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 0.4% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 23,081 shares of the medical instruments supplier’s stock after buying an additional 102 shares during the period. DENTSPLY SIRONA makes up about 1.5% of Security National Bank of Sioux City Iowa IA’s investment portfolio, making the stock its 23rd largest holding. Security National Bank of Sioux City Iowa IA’s holdings in DENTSPLY SIRONA were worth $1,497,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds also recently bought and sold shares of the stock. Vanguard Group Inc. increased its position in DENTSPLY SIRONA by 2.5% during the 2nd quarter. Vanguard Group Inc. now owns 22,728,062 shares of the medical instruments supplier’s stock valued at $1,473,688,000 after buying an additional 562,993 shares in the last quarter. BlackRock Inc. increased its position in DENTSPLY SIRONA by 3,103.7% during the 1st quarter. BlackRock Inc. now owns 13,891,329 shares of the medical instruments supplier’s stock valued at $867,376,000 after buying an additional 13,457,730 shares in the last quarter. State Street Corp increased its position in DENTSPLY SIRONA by 0.4% during the 1st quarter. State Street Corp now owns 9,931,689 shares of the medical instruments supplier’s stock valued at $620,136,000 after buying an additional 36,012 shares in the last quarter. Principal Financial Group Inc. increased its position in DENTSPLY SIRONA by 22.3% during the 2nd quarter. Principal Financial Group Inc. now owns 6,474,432 shares of the medical instruments supplier’s stock valued at $419,802,000 after buying an additional 1,181,547 shares in the last quarter. Finally, Veritas Asset Management LLP increased its position in DENTSPLY SIRONA by 2.6% during the 2nd quarter. Veritas Asset Management LLP now owns 6,201,155 shares of the medical instruments supplier’s stock valued at $402,083,000 after buying an additional 157,616 shares in the last quarter. 93.88% of the stock is owned by institutional investors.

DENTSPLY SIRONA Inc. (XRAY) traded down 1.58% during mid-day trading on Tuesday, hitting $57.17. The company’s stock had a trading volume of 713,025 shares. DENTSPLY SIRONA Inc. has a 12-month low of $52.54 and a 12-month high of $65.68. The company’s market cap is $13.12 billion. The firm’s 50-day moving average is $57.36 and its 200-day moving average is $61.21.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings results on Wednesday, August 9th. The medical instruments supplier reported $0.65 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.65. The business had revenue of $992.70 million for the quarter, compared to the consensus estimate of $1 billion. DENTSPLY SIRONA had a positive return on equity of 7.24% and a negative net margin of 20.57%. The business’s quarterly revenue was down 2.9% on a year-over-year basis. During the same period in the prior year, the firm posted $0.76 earnings per share. Analysts predict that DENTSPLY SIRONA Inc. will post $2.68 EPS for the current fiscal year.

A number of research firms recently weighed in on XRAY. HC Wainwright reaffirmed a “buy” rating and set a $68.00 price objective on shares of DENTSPLY SIRONA in a research report on Tuesday, October 3rd. Cleveland Research lowered DENTSPLY SIRONA from a “buy” rating to a “neutral” rating in a research report on Thursday, October 5th. Stifel Nicolaus reaffirmed a “buy” rating and set a $66.00 price objective (down previously from $70.00) on shares of DENTSPLY SIRONA in a research report on Thursday, August 10th. UBS AG reissued a “neutral” rating and issued a $59.00 target price (down previously from $62.00) on shares of DENTSPLY SIRONA in a report on Thursday, August 10th. Finally, Morgan Stanley reissued an “overweight” rating and issued a $69.00 target price (up previously from $67.00) on shares of DENTSPLY SIRONA in a report on Friday. Three investment analysts have rated the stock with a sell rating, three have assigned a hold rating and five have issued a buy rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus price target of $65.89.

WARNING: This story was first posted by Community Financial News and is the property of of Community Financial News. If you are accessing this story on another publication, it was copied illegally and reposted in violation of international copyright laws. The legal version of this story can be viewed at https://www.com-unik.info/2017/10/10/security-national-bank-of-sioux-city-iowa-ia-has-1-50-million-position-in-dentsply-sirona-inc-xray.html.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

What are top analysts saying about DENTSPLY SIRONA Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for DENTSPLY SIRONA Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit